None listed
Conditions
Brief summary
Type two diabetes is one of the fastest growing chronic diseases worldwide. Patients with type 2 diabetes must be committed to a daily routine to avoid diabetes complications. One of the problems they face is poor medication adherence. In this study we will test the feasability of Adherence Therapy which aims to help people to manage their medication more effectively. The therapy has not been tested among these patients. The objective of this study is to establish the feasibility of conducting Adherence Therapy in the Middle Eastern context. This is a randomized and unblinded study that aims to establish the feasibility of conducting Adherence Therapy in the Middle Eastern context. We aim to recruit 40 patients with diabetes. Patients who meet the eligibility criteria and provide consent will be randomly assigned into treatment as usual or Adherence Therapy. Randomization will be via the sealed envelope website (www.sealedenvelope.com). The online randomization website generates random allocation sequence. To prevent selection bias, randomization will take place after the baseline measures have been completed. Allocation won’t be concealed.
Interventions
Adherence therapy (AT) is a brief psychological intervention based on the principles of motivational interviewing (MI) and cognitive behavioural therapy (CBT). AT is a patient-centred approach delivered by a trained clinician over a series of 8 sessions weekly. Each session will take about half an hour. Key therapy techniques include adherence assessment (session 1) medication problem solving (session 2 and 3), exchanging information (session 4), exploring ambivalence (session 5 and 6), and chal
Adherence therapy (AT) is a brief psychological intervention based on the principles of motivational interviewing (MI) and cognitive behavioural therapy (CBT). AT is a patient-centred approach delivered by a trained clinician over a series of 8 sessions weekly. Each session will take about half an hour. Key therapy techniques include adherence assessment (session 1) medication problem solving (session 2 and 3), exchanging information (session 4), exploring ambivalence (session 5 and 6), and challenging beliefs (session 7 and 8). Theoretically, these techniques amplify the personally relevant benefits of treatment, modify illness and treatment beliefs, and resolve ambivalence towards taking medication. The intervention will be delivered over the telephone. Treatment fidelity will be checked by an independent rater against an AT scale using audio recordings of a random selection of sessions (approximately 4).
Sponsors
La Trobe University
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
• Adults aged 18 and over • Diagnosed with type two diabetes for at least 1 year. • Prescribed with a combination of diabetes medications • Non-adherent according to medication adherence rating (score<=7) • Participants that have access to a telephone
Exclusion criteria
• Participating in other clinical trials • Currently receiving any other psychological or psychosocial intervention • Patients with a terminal illness, brain injury, psychosis, dementia, cognitive impairment, or memory problem as these conditions might make it difficult for patients to engage in treatment. • Hearing impaired, as the program is delivered via phone and required the participants to communicate verbally.
Outcome results
None listed